• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Nω-羟基-L-精氨酸是L-精氨酸转化为一氧化氮途径中的一种中间体,是肝脏和巨噬细胞精氨酸酶的强效抑制剂。

N omega-hydroxyl-L-arginine, an intermediate in the L-arginine to nitric oxide pathway, is a strong inhibitor of liver and macrophage arginase.

作者信息

Boucher J L, Custot J, Vadon S, Delaforge M, Lepoivre M, Tenu J P, Yapo A, Mansuy D

机构信息

Laboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques, Université Paris V, CNRS URA 400, France.

出版信息

Biochem Biophys Res Commun. 1994 Sep 30;203(3):1614-21. doi: 10.1006/bbrc.1994.2371.

DOI:10.1006/bbrc.1994.2371
PMID:7945311
Abstract

N omega-Hydroxy-L-arginine (L-NOHA) is a potent inhibitor of the hydrolysis of L-arginine (L-Arg) to L-ornithine (L-Orn) catalyzed by purified bovine liver arginase (BLA). It appears as one of the most powerful arginase inhibitors reported so far (Ki = 150 microM). The other products of NO synthase are either without effect (NO2-, NO3-) or much weaker inhibitors (L-citrulline (L-Cit) and NO) of BLA. Products derived from a possible hydrolysis of L-Arg (L-Orn and urea) or of L-NOHA (L-Cit, hydroxyurea and hydroxylamine) are also inactive toward BLA at concentrations up to 2 mM. The configuration of L-NOHA is important as D-NOHA is much less active, and its free -COOH and alpha-NH2 functions are required for recognition of BLA. L-NOHA is also a potent inhibitor of the arginase activity of rat liver homogenates and of murine macrophages (IC50 of 150 and 450 microM, respectively). These remarkable properties of L-NOHA could play a role in the modulation of the biosynthesis of the biological mediator NO by increasing local L-Arg concentrations.

摘要

Nω-羟基-L-精氨酸(L-NOHA)是纯化的牛肝精氨酸酶(BLA)催化L-精氨酸(L-Arg)水解生成L-鸟氨酸(L-Orn)的强效抑制剂。它似乎是迄今为止报道的最强效的精氨酸酶抑制剂之一(Ki = 150微摩尔)。一氧化氮合酶的其他产物对BLA要么无作用(NO2-、NO3-),要么是较弱的抑制剂(L-瓜氨酸(L-Cit)和NO)。源自L-Arg(L-Orn和尿素)或L-NOHA(L-Cit、羟基脲和羟胺)可能水解的产物在浓度高达2毫摩尔时对BLA也无活性。L-NOHA的构型很重要,因为D-NOHA活性低得多,其游离的-COOH和α-NH2官能团是被BLA识别所必需的。L-NOHA也是大鼠肝脏匀浆和小鼠巨噬细胞精氨酸酶活性的强效抑制剂(IC50分别为150和450微摩尔)。L-NOHA的这些显著特性可能通过增加局部L-Arg浓度在生物介质NO生物合成的调节中发挥作用。

相似文献

1
N omega-hydroxyl-L-arginine, an intermediate in the L-arginine to nitric oxide pathway, is a strong inhibitor of liver and macrophage arginase.Nω-羟基-L-精氨酸是L-精氨酸转化为一氧化氮途径中的一种中间体,是肝脏和巨噬细胞精氨酸酶的强效抑制剂。
Biochem Biophys Res Commun. 1994 Sep 30;203(3):1614-21. doi: 10.1006/bbrc.1994.2371.
2
Effects of the new arginase inhibitor N(omega)-hydroxy-nor-L-arginine on NO synthase activity in murine macrophages.新型精氨酸酶抑制剂N(ω)-羟基-L-精氨酸对小鼠巨噬细胞中一氧化氮合酶活性的影响
Nitric Oxide. 1999 Dec;3(6):427-38. doi: 10.1006/niox.1999.0255.
3
Inhibition of arginase in rat and rabbit alveolar macrophages by N omega-hydroxy-D,L-indospicine, effects on L-arginine utilization by nitric oxide synthase.Nω-羟基-D,L-吲哚西辛对大鼠和兔肺泡巨噬细胞中精氨酸酶的抑制作用,及其对一氧化氮合酶利用L-精氨酸的影响。
Br J Pharmacol. 1997 Jun;121(3):395-400. doi: 10.1038/sj.bjp.0701143.
4
Effects of arginase inhibition via jugular infusion of N-hydroxy-nor-l-arginine on metabolic and immune indices in lactating dairy cows.颈静脉输注 N-羟基-N-正亮氨酸抑制精氨酸酶对泌乳奶牛代谢和免疫指标的影响。
J Dairy Sci. 2019 Apr;102(4):3310-3320. doi: 10.3168/jds.2018-14879. Epub 2019 Feb 7.
5
The vascular effects of different arginase inhibitors in rat isolated aorta and mesenteric arteries.不同精氨酸酶抑制剂对大鼠离体主动脉和肠系膜动脉的血管效应。
Br J Pharmacol. 2009 Jan;156(1):84-93. doi: 10.1111/j.1476-5381.2008.00036.x.
6
Modulation of cholinergic airway reactivity and nitric oxide production by endogenous arginase activity.内源性精氨酸酶活性对胆碱能气道反应性和一氧化氮生成的调节作用。
Br J Pharmacol. 2000 Aug;130(8):1793-8. doi: 10.1038/sj.bjp.0703488.
7
Inhibition of arginase via jugular infusion of N-hydroxy-nor-l-arginine inhibits casein synthesis in lactating dairy cows.经颈内静脉输注 N-羟基-N-正亮氨酸抑制泌乳奶牛的精氨酸酶活性,从而抑制乳蛋白合成。
J Dairy Sci. 2018 Apr;101(4):3514-3523. doi: 10.3168/jds.2017-13178. Epub 2018 Feb 4.
8
Short communication: Arginase inhibition reduces the synthesis of casein in bovine mammary epithelial cells.简短通讯:精氨酸酶抑制可减少牛乳腺上皮细胞中酪蛋白的合成。
J Dairy Sci. 2017 May;100(5):4128-4133. doi: 10.3168/jds.2016-11823. Epub 2017 Feb 23.
9
Liver I/R injury is improved by the arginase inhibitor, N(omega)-hydroxy-nor-L-arginine (nor-NOHA).精氨酸酶抑制剂N(ω)-羟基-L-精氨酸(nor-NOHA)可改善肝脏缺血/再灌注损伤。
Am J Physiol Gastrointest Liver Physiol. 2007 Feb;292(2):G512-7. doi: 10.1152/ajpgi.00227.2006. Epub 2006 Oct 5.
10
Inhibition of rat liver arginase by an intermediate in NO biosynthesis, NG-hydroxy-L-arginine: implications for the regulation of nitric oxide biosynthesis by arginase.一氧化氮生物合成中间体NG-羟基-L-精氨酸对大鼠肝脏精氨酸酶的抑制作用:精氨酸酶对一氧化氮生物合成的调节意义。
Biochem Biophys Res Commun. 1994 Jul 15;202(1):174-80. doi: 10.1006/bbrc.1994.1909.

引用本文的文献

1
Synthesis of Arginase Inhibitors: An Overview.精氨酸酶抑制剂的合成:综述
Pharmaceutics. 2025 Jan 16;17(1):117. doi: 10.3390/pharmaceutics17010117.
2
Reprogramming of breast tumor-associated macrophages with modulation of arginine metabolism.重塑肿瘤相关巨噬细胞的表型:调节精氨酸代谢途径
Life Sci Alliance. 2024 Aug 27;7(11). doi: 10.26508/lsa.202302339. Print 2024 Nov.
3
A colorimetric assay adapted to fragment screening revealing aurones and chalcones as new arginase inhibitors.一种适用于片段筛选的比色测定法揭示了奥酮类和查耳酮类作为新型精氨酸酶抑制剂。
RSC Med Chem. 2024 Feb 28;15(5):1722-1730. doi: 10.1039/d3md00713h. eCollection 2024 May 22.
4
Reprogramming of breast tumor-associated macrophages with modulation of arginine metabolism.通过调节精氨酸代谢对乳腺肿瘤相关巨噬细胞进行重编程。
bioRxiv. 2023 Aug 22:2023.08.22.554238. doi: 10.1101/2023.08.22.554238.
5
Towards Arginase Inhibition: Hybrid SAR Protocol for Property Mapping of Chlorinated -arylcinnamamides.迈向精氨酸酶抑制:用于氯化芳基肉桂酰胺性质图谱绘制的混合构效关系协议
Int J Mol Sci. 2023 Feb 10;24(4):3611. doi: 10.3390/ijms24043611.
6
Arginase: Biological and Therapeutic Implications in Diabetes Mellitus and Its Complications.精氨酸酶:在糖尿病及其并发症中的生物学和治疗意义。
Oxid Med Cell Longev. 2022 Oct 26;2022:2419412. doi: 10.1155/2022/2419412. eCollection 2022.
7
Arginase: shedding light on the mechanisms and opportunities in cardiovascular diseases.精氨酸酶:揭示心血管疾病的机制与机遇
Cell Death Discov. 2022 Oct 8;8(1):413. doi: 10.1038/s41420-022-01200-4.
8
Arginase as a Potential Biomarker of Disease Progression: A Molecular Imaging Perspective.精氨酸酶作为疾病进展的潜在生物标志物:分子影像学视角。
Int J Mol Sci. 2020 Jul 25;21(15):5291. doi: 10.3390/ijms21155291.
9
Endothelial Cell Metabolism.内皮细胞代谢
Physiol Rev. 2018 Jan 1;98(1):3-58. doi: 10.1152/physrev.00001.2017.
10
Arginase Structure and Inhibition: Catalytic Site Plasticity Reveals New Modulation Possibilities.精氨酸酶结构与抑制:催化位点可塑性揭示新的调控可能性。
Sci Rep. 2017 Oct 19;7(1):13616. doi: 10.1038/s41598-017-13366-4.